Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Huntingtin-interacting protein 1-related protein (HIP1R) is an endocytic adaptor protein that belongs to the Sla2/HIP1 family, characterized by domains for binding clathrin, inositol lipids, and F-actin[1][7]. HIP1R contains an AP180 N-terminal homology (ANTH) domain, a central coiled-coil region for clathrin light-chain binding, and a C-terminal THATCH domain for F-actin linkage[7]. It is ubiquitously expressed, especially in the brain, and is localized to clathrin-coated pits and vesicular structures, where it coordinates membrane trafficking and cytoskeletal dynamics during endocytosis[6][2]. HIP1R plays an important role in neural development, dendritic branching, and excitatory synapse formation; knockdown in primary neurons selectively impairs dendrite growth, glutamate receptor expression, and excitatory transmission[1][7]. Mechanistically, HIP1R stabilizes receptor tyrosine kinases such as EGFR after ligand-induced endocytosis and supports survival signaling[6][7]. Although HIP1R is structurally related to huntingtin-interacting protein 1 and does not interact directly with huntingtin or have a defined role in Huntington’s disease, genetic studies highlight its importance in neurobiology and other developmental processes[1][2][4]. No drugs currently target HIP1R directly, and no known clinical biomarkers or safety data exist for therapeutic manipulation of this protein.
Not therapeutically targeted; mechanistically, HIP1R regulates endocytosis, stabilizes receptor tyrosine kinases (e.g., EGFR) following ligand-induced endocytosis[7], links actin cytoskeleton to clathrin-coated vesicle formation[6][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Huntingtin-interacting protein 1-related protein (HIP1R).